[Federal Register Volume 85, Number 117 (Wednesday, June 17, 2020)]
[Notices]
[Page 36617]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13008]



[[Page 36617]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-667]


Importer of Controlled Substances Application: Woodfield 
Distribution, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 17, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before July 17, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on June 3, 2020, Woodfield Distribution, LLC, 951 Clint 
Moore Road, Suite A, Boca Raton, Florida 33487-2804, applied to be 
registered as an importer of the following basic class(es) of 
controlled substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code           Schedule
------------------------------------------------------------------------
Nabilone...............................     7379   II
------------------------------------------------------------------------

    The company plans to import this controlled substance for phase I 
of a clinical study. Approval of permit applications will occur only 
when the registrant's activity is consistent with what is authorized 
under 21 U.S.C. 952(a) (2). Authorization will not extend to the import 
of Food and Drug Administration (FDA)-approved or non-approved finished 
dosage forms for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-13008 Filed 6-16-20; 8:45 am]
BILLING CODE 4410-09-P